Earnings Ahead

HALO - Halozyme Therapeutics, Inc.

34.2 -0.64 -1.84

Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc.

About

Profile


Headquarters

San Diego, California, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

HALO



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Halozyme Therapeutics Non-GAAP EPS of $0.82 misses by $0.01, revenue of $230.04M misses by $1.1M
  • Halozyme Therapeutics Q4 2023 Earnings Preview
  • J&J seeks expanded FDA approval of Darzalex Faspro for multiple myeloma
  • EU okays Takeda's Hyqvia co-formulated with Halozyme's Enhanze
  • Lipocine licenses Tlando testosterone therapy to Verity Pharma
  • Regeneron’s high-dose Eylea, argenx’s Vyvgart injectable among latest approvals in Japan
  • Halozyme’s early 2023 results indicate a mixed performance
  • Halozyme gains as U.S. and EU clear Enhanze-based products
  • Top overweight stocks with high free cash flow and EPS growth - MS
  • JNJ multiple myeloma therapy outperforms standard of care by 58%
  • argenx slips as autoimmune disorder therapy fails in pivotal trial
  • Teva gains U.S. approval for generic version of osteoporosis injection
  • Argenx Vyvgart injectable granted EU nod for myasthenia gravis
  • Halozyme Therapeutics Non-GAAP EPS of $0.75 beats by $0.04, revenue of $216M in-line
  • Halozyme, Acumen enter collaboration for Alzheimer's drug candidate
  • Earnings week ahead: Disney, AMC, Plug Power, Lucid, Realty Income and more
  • Halozyme Therapeutics Q3 2023 Earnings Preview
  • Bristol Myers succeeds in Phase 3 trial for subcutaneous Opdivo
  • Roche granted U.K. approval for subcutaneous Tecentriq
  • Halozyme Therapeutics Non-GAAP EPS of $0.74 beats by $0.10, revenue of $221.04M beats by $21.09M
PEERS
/XLV

XLV

Date Price Open High Low Vol Change
Nov 20 45.76 44.57
46.2
44.1
1.8M 2.12%
Nov 19 44.81 43.81
45.3
42.65
3.8M 5.26%
Nov 18 42.57 45.66
45.71
42.01
5.5M -6.75%
Nov 15 45.65 48.81
49.64
45.63
7.2M -15.4%
Nov 14 53.96 58.25
59.8
53.84
3.2M -7.93%
 
Nov 13 58.61 59.79
60.37
58.46
831K -1.68%
Nov 12 59.61 61.08
62.02
59.24
1.5M -2.42%
Nov 11 61.09 61.13
62.13
60.55
1.5M 0.18%
Nov 8 60.98 59.65
61.19
59.14
1.1M 2.23%
Nov 7 59.65 60.66
60.95
58.76
1.1M -1.62%
Nov 6 60.63 60.55
61.49
58.01
1.5M 3.25%
Nov 5 58.72 58
58.74
57.08
1.1M 0.43%
Nov 4 58.47 56.82
59.39
56.82
2.1M 2.31%
Nov 1 57.15 55.65
57.62
52.56
3.4M 13.01%
Oct 31 50.57 50.56
51.21
50.01
1.9M -0.04%
Oct 30 50.59 50.46
51.08
50.03
741K -0.1%
Oct 29 50.64 50.17
50.96
50.1
538K 0.36%
Oct 28 50.46 49.72
50.78
49.71
1.2M 2.46%
Oct 25 49.25 49.35
49.84
48.84
790K -0.1%
Oct 24 49.3 50.79
50.79
49.12
1.0M -2.95%
Oct 23 50.8 51.46
51.7
50.51
992K -1.45%
Oct 22 51.55 51.68
52.03
51.14
1.1M -0.42%
Oct 21 51.77 52.6
52.77
51.45
1.1M -1.6%
Oct 18 52.61 52.2
53.09
52.2
901K 0.63%
Oct 17 52.28 53.46
53.6
52.1
1.2M -2.21%
Oct 16 53.46 53.43
53.7
52.83
932K -0.67%
Oct 15 53.82 53.84
54.66
53.24
800K -0.24%
Oct 14 53.95 53.02
54.45
52.93
820K 1.79%
Oct 11 53 52.26
53.14
52.15
862K 1.67%
Oct 10 52.13 50.34
52.23
50.27
2.1M 2.90%
Oct 9 50.66 54
54.41
49.63
3.5M -6.41%
Oct 8 54.13 54.33
55
53.25
2.1M 0.52%
Oct 7 53.85 57.92
57.98
53.32
2.5M -9.01%
Oct 4 59.18 60.56
61.56
58.51
1.1M -2.07%
Oct 3 60.43 58.12
62
57.63
1.9M 3.90%
Oct 2 58.16 56.55
58.39
56.2
1.3M 2.68%
Oct 1 56.64 56.97
57.19
55.89
1.3M -1.05%
Sep 30 57.24 56.87
57.59
56.53
961K 0.47%
Sep 27 56.97 57.35
58.04
56.84
1.2M 0.04%
Sep 26 56.95 55.91
57.04
55.8
1.6M 1.93%
Sep 25 55.87 56.5
56.67
55.43
1.3M -0.59%
Sep 24 56.2 58.6
58.6
55.95
2.2M -3.98%
Sep 23 58.53 59.62
59.62
58.41
988K -1.2%
Sep 20 59.24 59.83
59.83
58.71
2.7M -0.44%
Sep 19 59.5 62.48
62.8
59.1
1.7M -4.51%
Sep 18 62.31 61.93
63.5
61.3
1.2M 0.61%
Sep 17 61.93 62.91
63.28
61.25
1.5M -1.56%
Sep 16 62.91 62.78
63.45
62.56
1.2M 0.98%
Sep 13 62.3 61.02
62.93
61
942K 2.91%
Sep 12 60.54 59.43
61.34
58.91
1.1M 1.94%
Sep 11 59.39 59.01
60.14
58.64
719K 0.22%
Sep 10 59.26 59.23
59.84
58.59
765K 0.03%
Sep 9 59.24 59.95
59.95
58.81
1.4M 0.05%
Sep 6 59.21 61.25
61.64
58.94
1.1M -3.01%
Sep 5 61.05 62.5
62.81
60.45
881K -1.74%
Sep 4 62.13 61
62.2
60.82
920K 1.49%
Sep 3 61.22 63.59
64.18
61.04
2.3M -4.12%
Aug 30 63.85 63.76
64.3
63.23
960K 0.17%
Aug 29 63.74 64.98
65.53
63.6
1.8M -1.06%
Aug 28 64.42 63.03
65
62.97
1.3M 0%